Research into glioma, a type of tumor, is exploring various pathways to develop innovative therapies. Studies are investigating different approaches, including targeting regulated cell death, epigenetic underpinnings of inflammation, and the gut-brain-microbiome axis, to better understand and potentially treat the disease. The investigations are also examining the potential of new strategies, such as metabolic reprogramming and nanoimmunotherapy, to overcome therapy resistance in glioma patients.